STIM1 and melanoma: Integration of malignant-cell-derived SCGs with data from bulk melanoma specimens and Reactome pathways further connects STIM1 to alterations in calcium signaling, cell cycle regulation, and unexpectedly, immune-related cellular pathways in malignant melanoma cells (Figure 3A and Supplementary Figure S13).